Literature DB >> 27760413

What is the impact of impaired left ventricular ejection fraction in COPD after adjusting for confounders?

Rafael Mesquita1, Frits M E Franssen2, Sarah Houben-Wilke2, Nicole H M K Uszko-Lencer3, Lowie E G W Vanfleteren4, Yvonne M J Goërtz2, Fabio Pitta5, Emiel F M Wouters4, Martijn A Spruit2.   

Abstract

BACKGROUND: It remains unknown whether and to what extent impaired left ventricular ejection fraction (LVEF) affects physical and psychological status in COPD. We aimed to compare health outcome measures between COPD patients with and without impaired LVEF after adjusting for age, sex, BMI and FEV1.
METHODS: Impaired LVEF was defined as values <50%. 85 COPD patients with impaired LVEF and 85 COPD patients with normal LVEF were matched for sex, age, BMI and FEV1. Exercise capacity, quadriceps muscle function, functional mobility, inflammatory status, health status, care dependency, and mood disorders were cross-sectionally assessed.
RESULTS: Patients with impaired LVEF had shorter 6-minute walk distance (mean -59 (95% confidence interval: -94, -25)m), lower symptom-limited peak oxygen uptake (-131 (-268, 7)ml/min), weaker quadriceps muscles (-12 (-20, -3)Nm) and had more symptoms of anxiety (+2 (1, 3) points) and depression (+1 (0, 2) points) than those with normal LVEF (all P<0.05). Health status was not statistically different between groups (P>0.05).
CONCLUSIONS: Impaired LVEF has a clear impact on physical and psychological status in patients with COPD, even after adjusting for confounders. This reinforces the importance of assessing and treating cardiac problems in COPD.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chronic heart failure; Chronic obstructive pulmonary disease; Comorbidity; Outcome assessment (health care)

Mesh:

Year:  2016        PMID: 27760413     DOI: 10.1016/j.ijcard.2016.10.016

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Association of Accelerometer-Measured Light-Intensity Physical Activity With Brain Volume: The Framingham Heart Study.

Authors:  Nicole L Spartano; Kendra L Davis-Plourde; Jayandra J Himali; Charlotte Andersson; Matthew P Pase; Pauline Maillard; Charles DeCarli; Joanne M Murabito; Alexa S Beiser; Ramachandran S Vasan; Sudha Seshadri
Journal:  JAMA Netw Open       Date:  2019-04-05

2.  Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.

Authors:  Thierry Perez; Gaëtan Deslée; Pierre Régis Burgel; Denis Caillaud; Olivier Le Rouzic; Maeva Zysman; Roger Escamilla; Gilles Jebrak; Pascal Chanez; Isabelle Court-Fortune; Graziella Brinchault-Rabin; Pascale Nesme-Meyer; Jean-Louis Paillasseur; Nicolas Roche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-02

3.  Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort.

Authors:  Peter Alter; Barbara A Mayerhofer; Kathrin Kahnert; Henrik Watz; Benjamin Waschki; Stefan Andreas; Frank Biertz; Robert Bals; Claus F Vogelmeier; Rudolf A Jörres
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-20

4.  Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary disease.

Authors:  Yu-Chen Huang; Ting-Yu Lin; Hau-Tieng Wu; Po-Jui Chang; Chun-Yu Lo; Tsai-Yu Wang; Chih-Hsi Scott Kuo; Shu-Min Lin; Fu-Tsai Chung; Horng-Chyuan Lin; Meng-Heng Hsieh; Yu-Lun Lo
Journal:  BMC Pulm Med       Date:  2021-01-12       Impact factor: 3.317

5.  Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores.

Authors:  Sarah Houben-Wilke; Daisy J A Janssen; Frits M E Franssen; Lowie E G W Vanfleteren; Emiel F M Wouters; Martijn A Spruit
Journal:  Health Qual Life Outcomes       Date:  2018-10-30       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.